home
***
CD-ROM
|
disk
|
FTP
|
other
***
search
/
The Arsenal Files 6
/
The Arsenal Files 6 (Arsenal Computer).ISO
/
health
/
med9604b.zip
/
M9640755.TXT
< prev
next >
Wrap
Text File
|
1996-03-04
|
3KB
|
41 lines
Document 0755
DOCN M9640755
TI Differences in participation in experimental drug trials among persons
with AIDS.
DT 9604
AU Diaz T; Chu SY; Sorvillo F; Mokotoff E; Davidson AJ; Samuel MC; Herr M;
Doyle B; Frederick M; Fann SA; et al; Division of HIV/AIDS, Centers for
Disease Control and Prevention,; Atlanta, GA 30333, USA.
SO J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):562-8.
Unique Identifier : AIDSLINE MED/96142219
AB To measure participation in experimental drug trials among persons with
acquired immunodeficiency syndrome (AIDS), we interviewed 4,604 persons
at least 18 years of age who were reported to have AIDS to 11 state and
city health departments in the United States. Ten percent reported that
they were currently in a trial. Current enrollment differed
significantly (p < 0.05) by race/ethnicity (blacks, 5%; whites, 14%;
Hispanics, 15%), gender (women, 7%; men, 11%), exposure mode (injection
drug use, 5%, men who have sex with men, 14%), annual household income
(< $10,000, 8%, > or = $10,000, 14%), education (< 12 years, 6%; > or =
12 years, 12%), health care (no regular care, 1%, public care, 8%;
private care, 17%), and time since AIDS diagnosis (< or = 6 months, 9%;
> 6 months, 12%). Adjusting for all factors and time since AIDS
diagnosis, blacks (adjusted odds ratio [AOR] = 0.35, 95% confidence
interval [CI] 0.26, 0.47), persons with less than 12 years of education
(AOR = 0.71, CI 0.53, 0.96), and those without regular health care (AOR
= 0.24, CI 0.10, 0.61) remained less likely to be in a trial. Blacks,
those with less than 12 years of education, and persons without regular
health care were less likely than other persons with AIDS to be
currently enrolled in AIDS trials. To increase enrollment of these
persons, researchers must address barriers to participation for these
groups.
DE Acquired Immunodeficiency Syndrome/*DRUG THERAPY/EPIDEMIOLOGY
Adolescence Adult Antiviral Agents/*THERAPEUTIC USE Clinical
Trials/*STATISTICS & NUMER DATA Ethnic Groups Female Human Male
Patient Participation/*STATISTICS & NUMER DATA Socioeconomic Factors
United States/EPIDEMIOLOGY JOURNAL ARTICLE MULTICENTER STUDY
SOURCE: National Library of Medicine. NOTICE: This material may be
protected by Copyright Law (Title 17, U.S.Code).